← Back to Search

Nicotinic Acetylcholine Receptor Agonist

Nicotine patch for Parkinson's Disease

Phase 4

Waitlist Available

Led By James Boyd, MD

Research Sponsored by University of Vermont

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12-20 minutes

Awards & highlights

Study Summary

The specific aims of this study are to examine whether treatment with transdermal nicotine improves computer-based laboratory and clinical measures of impulsive and compulsive behaviors in Parkinson's Disease subjects who have recently experienced an impulse control disorder.

Eligible Conditions

Parkinson's Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12-20 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12-20 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Stop Signal task

Secondary outcome measures

Set shifting task

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Nicotine patchActive Control1 Intervention

Group II: Placebo patchPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of VermontLead Sponsor

266 Previous Clinical Trials

3,743,671 Total Patients Enrolled

Parkinson's Disease FoundationOTHER

9 Previous Clinical Trials

817 Total Patients Enrolled

The Parkinson Study GroupNETWORK

15 Previous Clinical Trials

21,985 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

clinicaltrials.govStudy

Nicotine Treatment of Impulsivity in Parkinson's Disease

James BOYD MD 2010. "Nicotine Treatment of Impulsivity in Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01216904.

All > Parkinson

~1 spots leftby Apr 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.